Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)
China · Delayed Price · Currency is CNY 37.48
-0.87 (-2.27%)
May 12, 2026, 3:00 PM CST
Assure Tech (Hangzhou) Revenue
Assure Tech (Hangzhou) had revenue of 71.20M CNY in the quarter ending March 31, 2026, a decrease of -38.25%. This brings the company's revenue in the last twelve months to 407.16M, down -22.68% year-over-year. In the year 2025, Assure Tech (Hangzhou) had annual revenue of 451.26M, down -16.54%.
Revenue (ttm)
407.16M
Revenue Growth
-22.68%
P/S Ratio
11.97
Revenue / Employee
549.47K
Employees
720
Market Cap
4.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 451.26M | -89.44M | -16.54% |
| Dec 31, 2024 | 540.70M | 37.34M | 7.42% |
| Dec 31, 2023 | 503.36M | -5.66B | -91.84% |
| Dec 31, 2022 | 6.17B | 4.58B | 287.97% |
| Dec 31, 2021 | 1.59B | 389.51M | 32.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Hvsen Biotechnology | 1.74B |
| Hefei Lifeon Pharmaceutical | 1.55B |
| Kexing Biopharm | 1.46B |
| ChemPartner PharmaTech | 1.14B |
| Boji Medical Technology | 949.94M |
| Beijing Bohui Innovation Biotechnology Group | 812.78M |
| Beijing Scitop Bio-tech | 373.31M |
| Jiangsu Bioperfectus Technologies | 326.02M |